Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ

Gespeichert in:

Autor*in:	Sh. Kh. Gantsev [verfasserIn] Kazuo Umezawa [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Russisch

Erschienen:	2019

Schlagwörter:	nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq

Übergeordnetes Werk:	In: Креативная хирургия и онкология - Bashkir State Medical University, 2019, 9(2019), 1, Seite 87-88
Übergeordnetes Werk:	volume:9 ; year:2019 ; number:1 ; pages:87-88

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.24060/2076-3093-2019-9-1-87-88

Katalog-ID:	DOAJ000313300

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ000313300
003	DE-627
005	20230410115517.0
007	cr uuu---uuuuu
008	230225s2019 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.24060/2076-3093-2019-9-1-87-88 \|2 doi
035			\|a (DE-627)DOAJ000313300
035			\|a (DE-599)DOAJae8ec7121fa346cca93b833fe5444e33
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a rus
050		0	\|a RD1-811
050		0	\|a RC254-282
100	0		\|a Sh. Kh. Gantsev \|e verfasserin \|4 aut
245	1	0	\|a Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
264		1	\|c 2019
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a .
650		4	\|a nf-kappa b
650		4	\|a cancer
650		4	\|a leukemia
650		4	\|a dehydroxymethylepoxyquinomicin
650		4	\|a dhmeq
653		0	\|a Surgery
653		0	\|a Neoplasms. Tumors. Oncology. Including cancer and carcinogens
700	0		\|a Kazuo Umezawa \|e verfasserin \|4 aut
773	0	8	\|i In \|t Креативная хирургия и онкология \|d Bashkir State Medical University, 2019 \|g 9(2019), 1, Seite 87-88 \|w (DE-627)1760593990 \|x 23070501 \|7 nnns
773	1	8	\|g volume:9 \|g year:2019 \|g number:1 \|g pages:87-88
856	4	0	\|u https://doi.org/10.24060/2076-3093-2019-9-1-87-88 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33 \|z kostenfrei
856	4	0	\|u https://www.surgonco.ru/jour/article/view/368 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2307-0501 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2076-3093 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
951			\|a AR
952			\|d 9 \|j 2019 \|e 1 \|h 87-88

Indexfelder

author_variant	s k g skg k u ku
matchkey_str	article:23070501:2019----::motnefoeitaeioelhrponk
hierarchy_sort_str	2019
callnumber-subject-code	RD
publishDate	2019
allfields	10.24060/2076-3093-2019-9-1-87-88 doi (DE-627)DOAJ000313300 (DE-599)DOAJae8ec7121fa346cca93b833fe5444e33 DE-627 ger DE-627 rakwb eng rus RD1-811 RC254-282 Sh. Kh. Gantsev verfasserin aut Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier . nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq Surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens Kazuo Umezawa verfasserin aut In Креативная хирургия и онкология Bashkir State Medical University, 2019 9(2019), 1, Seite 87-88 (DE-627)1760593990 23070501 nnns volume:9 year:2019 number:1 pages:87-88 https://doi.org/10.24060/2076-3093-2019-9-1-87-88 kostenfrei https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33 kostenfrei https://www.surgonco.ru/jour/article/view/368 kostenfrei https://doaj.org/toc/2307-0501 Journal toc kostenfrei https://doaj.org/toc/2076-3093 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 9 2019 1 87-88
spelling	10.24060/2076-3093-2019-9-1-87-88 doi (DE-627)DOAJ000313300 (DE-599)DOAJae8ec7121fa346cca93b833fe5444e33 DE-627 ger DE-627 rakwb eng rus RD1-811 RC254-282 Sh. Kh. Gantsev verfasserin aut Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier . nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq Surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens Kazuo Umezawa verfasserin aut In Креативная хирургия и онкология Bashkir State Medical University, 2019 9(2019), 1, Seite 87-88 (DE-627)1760593990 23070501 nnns volume:9 year:2019 number:1 pages:87-88 https://doi.org/10.24060/2076-3093-2019-9-1-87-88 kostenfrei https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33 kostenfrei https://www.surgonco.ru/jour/article/view/368 kostenfrei https://doaj.org/toc/2307-0501 Journal toc kostenfrei https://doaj.org/toc/2076-3093 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 9 2019 1 87-88
allfields_unstemmed	10.24060/2076-3093-2019-9-1-87-88 doi (DE-627)DOAJ000313300 (DE-599)DOAJae8ec7121fa346cca93b833fe5444e33 DE-627 ger DE-627 rakwb eng rus RD1-811 RC254-282 Sh. Kh. Gantsev verfasserin aut Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier . nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq Surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens Kazuo Umezawa verfasserin aut In Креативная хирургия и онкология Bashkir State Medical University, 2019 9(2019), 1, Seite 87-88 (DE-627)1760593990 23070501 nnns volume:9 year:2019 number:1 pages:87-88 https://doi.org/10.24060/2076-3093-2019-9-1-87-88 kostenfrei https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33 kostenfrei https://www.surgonco.ru/jour/article/view/368 kostenfrei https://doaj.org/toc/2307-0501 Journal toc kostenfrei https://doaj.org/toc/2076-3093 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 9 2019 1 87-88
allfieldsGer	10.24060/2076-3093-2019-9-1-87-88 doi (DE-627)DOAJ000313300 (DE-599)DOAJae8ec7121fa346cca93b833fe5444e33 DE-627 ger DE-627 rakwb eng rus RD1-811 RC254-282 Sh. Kh. Gantsev verfasserin aut Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier . nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq Surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens Kazuo Umezawa verfasserin aut In Креативная хирургия и онкология Bashkir State Medical University, 2019 9(2019), 1, Seite 87-88 (DE-627)1760593990 23070501 nnns volume:9 year:2019 number:1 pages:87-88 https://doi.org/10.24060/2076-3093-2019-9-1-87-88 kostenfrei https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33 kostenfrei https://www.surgonco.ru/jour/article/view/368 kostenfrei https://doaj.org/toc/2307-0501 Journal toc kostenfrei https://doaj.org/toc/2076-3093 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 9 2019 1 87-88
allfieldsSound	10.24060/2076-3093-2019-9-1-87-88 doi (DE-627)DOAJ000313300 (DE-599)DOAJae8ec7121fa346cca93b833fe5444e33 DE-627 ger DE-627 rakwb eng rus RD1-811 RC254-282 Sh. Kh. Gantsev verfasserin aut Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier . nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq Surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens Kazuo Umezawa verfasserin aut In Креативная хирургия и онкология Bashkir State Medical University, 2019 9(2019), 1, Seite 87-88 (DE-627)1760593990 23070501 nnns volume:9 year:2019 number:1 pages:87-88 https://doi.org/10.24060/2076-3093-2019-9-1-87-88 kostenfrei https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33 kostenfrei https://www.surgonco.ru/jour/article/view/368 kostenfrei https://doaj.org/toc/2307-0501 Journal toc kostenfrei https://doaj.org/toc/2076-3093 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 9 2019 1 87-88
language	English Russian
source	In Креативная хирургия и онкология 9(2019), 1, Seite 87-88 volume:9 year:2019 number:1 pages:87-88
sourceStr	In Креативная хирургия и онкология 9(2019), 1, Seite 87-88 volume:9 year:2019 number:1 pages:87-88
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq Surgery Neoplasms. Tumors. Oncology. Including cancer and carcinogens
isfreeaccess_bool	true
container_title	Креативная хирургия и онкология
authorswithroles_txt_mv	Sh. Kh. Gantsev @@aut@@ Kazuo Umezawa @@aut@@
publishDateDaySort_date	2019-01-01T00:00:00Z
hierarchy_top_id	1760593990
id	DOAJ000313300
language_de	englisch russisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ000313300</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410115517.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2019 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.24060/2076-3093-2019-9-1-87-88</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ000313300</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJae8ec7121fa346cca93b833fe5444e33</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Sh. Kh. Gantsev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nf-kappa b</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">leukemia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">dehydroxymethylepoxyquinomicin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">dhmeq</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kazuo Umezawa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Креативная хирургия и онкология</subfield><subfield code="d">Bashkir State Medical University, 2019</subfield><subfield code="g">9(2019), 1, Seite 87-88</subfield><subfield code="w">(DE-627)1760593990</subfield><subfield code="x">23070501</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:87-88</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.24060/2076-3093-2019-9-1-87-88</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.surgonco.ru/jour/article/view/368</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2307-0501</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-3093</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">87-88</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Sh. Kh. Gantsev
spellingShingle	Sh. Kh. Gantsev misc RD1-811 misc RC254-282 misc nf-kappa b misc cancer misc leukemia misc dehydroxymethylepoxyquinomicin misc dhmeq misc Surgery misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
authorStr	Sh. Kh. Gantsev
ppnlink_with_tag_str_mv	@@773@@(DE-627)1760593990
format	electronic Article
delete_txt_mv	keep
author_role	aut aut
collection	DOAJ
remote_str	true
callnumber-label	RD1-811
illustrated	Not Illustrated
issn	23070501
topic_title	RD1-811 RC254-282 Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ nf-kappa b cancer leukemia dehydroxymethylepoxyquinomicin dhmeq
topic	misc RD1-811 misc RC254-282 misc nf-kappa b misc cancer misc leukemia misc dehydroxymethylepoxyquinomicin misc dhmeq misc Surgery misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_unstemmed	misc RD1-811 misc RC254-282 misc nf-kappa b misc cancer misc leukemia misc dehydroxymethylepoxyquinomicin misc dhmeq misc Surgery misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
topic_browse	misc RD1-811 misc RC254-282 misc nf-kappa b misc cancer misc leukemia misc dehydroxymethylepoxyquinomicin misc dhmeq misc Surgery misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Креативная хирургия и онкология
hierarchy_parent_id	1760593990
hierarchy_top_title	Креативная хирургия и онкология
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1760593990
title	Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
ctrlnum	(DE-627)DOAJ000313300 (DE-599)DOAJae8ec7121fa346cca93b833fe5444e33
title_full	Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
author_sort	Sh. Kh. Gantsev
journal	Креативная хирургия и онкология
journalStr	Креативная хирургия и онкология
callnumber-first-code	R
lang_code	eng rus
isOA_bool	true
recordtype	marc
publishDateSort	2019
contenttype_str_mv	txt
container_start_page	87
author_browse	Sh. Kh. Gantsev Kazuo Umezawa
container_volume	9
class	RD1-811 RC254-282
format_se	Elektronische Aufsätze
author-letter	Sh. Kh. Gantsev
doi_str_mv	10.24060/2076-3093-2019-9-1-87-88
author2-role	verfasserin
title_sort	importance of novel intraperitoneal therapy of nf-kappa b inhibitor dhmeq
callnumber	RD1-811
title_auth	Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
abstract	.
abstractGer	.
abstract_unstemmed	.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ
container_issue	1
title_short	Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
url	https://doi.org/10.24060/2076-3093-2019-9-1-87-88 https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33 https://www.surgonco.ru/jour/article/view/368 https://doaj.org/toc/2307-0501 https://doaj.org/toc/2076-3093
remote_bool	true
author2	Kazuo Umezawa
author2Str	Kazuo Umezawa
ppnlink	1760593990
callnumber-subject	RD - Surgery
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.24060/2076-3093-2019-9-1-87-88
callnumber-a	RD1-811
up_date	2024-07-03T14:04:55.442Z
_version_	1803566968156979200
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ000313300</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410115517.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2019 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.24060/2076-3093-2019-9-1-87-88</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ000313300</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJae8ec7121fa346cca93b833fe5444e33</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Sh. Kh. Gantsev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nf-kappa b</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">leukemia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">dehydroxymethylepoxyquinomicin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">dhmeq</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kazuo Umezawa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Креативная хирургия и онкология</subfield><subfield code="d">Bashkir State Medical University, 2019</subfield><subfield code="g">9(2019), 1, Seite 87-88</subfield><subfield code="w">(DE-627)1760593990</subfield><subfield code="x">23070501</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:87-88</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.24060/2076-3093-2019-9-1-87-88</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ae8ec7121fa346cca93b833fe5444e33</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.surgonco.ru/jour/article/view/368</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2307-0501</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-3093</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">87-88</subfield></datafield></record></collection>
score	7.4010115

Nicht das Richtige dabei?

Schreiben Sie uns!

Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?